Clinical Pharmacology OverviewFrom the Antiviral Perspective
New concepts in HIV Immunology Pr Brigitte AUTRAN Lab. Immunité et Infections, INSERM U945 Institut Fédératif de Recherches Immunité-Cancer-Infection Hôpital.
Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration.
HIV clinical issues for case managers
Handout 1
Scaling up testing and counselling as it looks from treatment data monitoring perspectives: The applied research outcomes and the policy implications it.
CROI Review: ARV and Other Issues of Interest
Management of occup exposures
K
Donor Selection: Sibling. Prof Miguel A Sanz
Fundamentals_Fri_Melendez_Resistance.pdf
Presented by Keith W. Crawford, R.Ph., Ph.D. Clinical Research Associate, Department of Clinical Pharmacology, Johns Hopkins School of Medicine, Clinical.
